Financial statements Hemolens Diagnostics

Cash flow statement of Hemolens Diagnostics

Company age:
Age:
9 y. 11 m. 16 d.
Share capital:
Share capital:
25 650 PLN

Cash inflows of HEMOLENS DIAGNOSTICS

Year
2018
2019
2020
2022
2023
Net cash from operating expenses - 2 829 457,61 - - -29 156 795,19
Net cash flow from investing activities - -82 616,86 - - -568 853,77
Net cash flow from financial activities - 0,00 - - 34 288 538,36
Total net cash flow - 2 746 840,75 - - 4 562 889,40
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.